SI1648484T1 - Farmacevtske oblike za zdravljenje artritiäśnih stanj - Google Patents
Farmacevtske oblike za zdravljenje artritiäśnih stanjInfo
- Publication number
- SI1648484T1 SI1648484T1 SI200430968T SI200430968T SI1648484T1 SI 1648484 T1 SI1648484 T1 SI 1648484T1 SI 200430968 T SI200430968 T SI 200430968T SI 200430968 T SI200430968 T SI 200430968T SI 1648484 T1 SI1648484 T1 SI 1648484T1
- Authority
- SI
- Slovenia
- Prior art keywords
- formulations
- treatment
- arhritis conditions
- conditions
- arhritis
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- NBGQZFQREPIKMG-UHFFFAOYSA-N 3beta-hydroxy-beta-boswellic acid Natural products C1CC(O)C(C)(C(O)=O)C2CCC3(C)C4(C)CCC5(C)CCC(C)C(C)C5C4=CCC3C21C NBGQZFQREPIKMG-UHFFFAOYSA-N 0.000 abstract 1
- NBGQZFQREPIKMG-PONOSELZSA-N Boswellic acid Chemical compound C1C[C@@H](O)[C@](C)(C(O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C NBGQZFQREPIKMG-PONOSELZSA-N 0.000 abstract 1
- CWEZAWNPTYBADX-UHFFFAOYSA-N Procyanidin Natural products OC1C(OC2C(O)C(Oc3c2c(O)cc(O)c3C4C(O)C(Oc5cc(O)cc(O)c45)c6ccc(O)c(O)c6)c7ccc(O)c(O)c7)c8c(O)cc(O)cc8OC1c9ccc(O)c(O)c9 CWEZAWNPTYBADX-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 206010003246 arthritis Diseases 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 229960002442 glucosamine Drugs 0.000 abstract 1
- 230000002519 immonomodulatory effect Effects 0.000 abstract 1
- 229920002414 procyanidin Polymers 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/76—Salicaceae (Willow family), e.g. poplar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Molecular Biology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Road Signs Or Road Markings (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT001311A ITMI20031311A1 (it) | 2003-06-27 | 2003-06-27 | Formulazioni per il trattamento di disturbi artrosici. |
| PCT/EP2004/005875 WO2005002611A1 (en) | 2003-06-27 | 2004-06-01 | Formulations for the treatment of arhritis conditions |
| EP04735566A EP1648484B1 (en) | 2003-06-27 | 2004-06-01 | Formulations for the treatment of arhritis conditions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI1648484T1 true SI1648484T1 (sl) | 2009-02-28 |
Family
ID=30131307
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200430968T SI1648484T1 (sl) | 2003-06-27 | 2004-06-01 | Farmacevtske oblike za zdravljenje artritiäśnih stanj |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US8343554B2 (sl) |
| EP (1) | EP1648484B1 (sl) |
| JP (1) | JP2007513051A (sl) |
| KR (2) | KR20110039400A (sl) |
| CN (1) | CN1812802A (sl) |
| AT (1) | ATE414526T1 (sl) |
| AU (1) | AU2004253242B2 (sl) |
| BR (1) | BRPI0411895B1 (sl) |
| CA (1) | CA2530494C (sl) |
| DE (1) | DE602004017871D1 (sl) |
| DK (1) | DK1648484T3 (sl) |
| ES (1) | ES2315662T3 (sl) |
| IL (1) | IL172773A (sl) |
| IT (1) | ITMI20031311A1 (sl) |
| NO (1) | NO333877B1 (sl) |
| NZ (1) | NZ544400A (sl) |
| PL (1) | PL1648484T3 (sl) |
| PT (1) | PT1648484E (sl) |
| RU (1) | RU2349336C2 (sl) |
| SI (1) | SI1648484T1 (sl) |
| WO (1) | WO2005002611A1 (sl) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITRM20040439A1 (it) * | 2004-09-16 | 2004-12-16 | Ca Di Group S R L | Prodotto con azione antinfiammatoria selettiva e azione contro la fibrogenesi tissutale. |
| ITMI20051349A1 (it) * | 2005-07-14 | 2007-01-15 | Indena Spa | Estratto di salice uso e formulazioni che lo contengono |
| CN100417415C (zh) * | 2006-06-28 | 2008-09-10 | 文彦春 | 浸润治疗关节炎的药物 |
| EP1886712A1 (en) | 2006-08-08 | 2008-02-13 | Indena S.P.A. | Compositions for the treatment of chronic degenerative inflammatory conditions |
| FR2907339B1 (fr) * | 2006-10-20 | 2009-04-24 | Inneov Lab | Composition comprenant de la glucosamine et au moins un polyphenol. |
| CN101371823B (zh) * | 2007-03-19 | 2010-09-15 | 上海慈瑞医药科技有限公司 | 二乙酰大黄酸缓释胶囊的制备工艺 |
| FR2918376B1 (fr) | 2007-07-04 | 2011-10-28 | Mathieu Borge | Compositions liquides ou pateuses destinees a l'apport en elements essentiels a la synthese et a la constitution des proteoglycanes, notamment pour le traitement de la degradation du cartilage |
| JP2010538058A (ja) * | 2007-09-04 | 2010-12-09 | カトリック ユニバーシティ インダストリー アカデミック コーオペレイション ファウンデーション | ビティス・ビニフェラの種抽出物の調製方法及び該抽出物を含む関節リウマチの予防または治療用の医薬組成物 |
| WO2010029578A2 (en) | 2008-09-15 | 2010-03-18 | Ganga Raju Gokaraju | Synergistic anti-inflammatory compositions comprising boswellia serrata extracts |
| KR101096574B1 (ko) * | 2008-12-12 | 2011-12-20 | 에이치 엘 지노믹스(주) | 유럽종 포도의 씨 추출물을 함유하는 골다공증 예방 또는 치료용 약학 조성물 |
| KR101099021B1 (ko) * | 2009-04-24 | 2011-12-28 | 에이치 엘 지노믹스(주) | 유럽종 포도의 씨 추출물을 함유하는 골관절염 예방 또는 치료용 약학 조성물 |
| JP5734578B2 (ja) * | 2009-09-03 | 2015-06-17 | ナガセケムテックス株式会社 | ヒアルロン酸増量剤 |
| WO2011079203A1 (en) * | 2009-12-23 | 2011-06-30 | Bae Systems Aerospace & Defense Group Inc. | Quick release buckle with dual release |
| CN102711781B (zh) | 2010-02-15 | 2016-05-04 | 莱拉营养食品有限公司 | 一种乳香低极性树胶脂提取物及其协同增效的组合物 |
| US8828377B2 (en) | 2010-03-15 | 2014-09-09 | Laila Nutraceuticals | Boswellia oil, its fractions and compositions for enhancing brain function |
| WO2012177825A1 (en) | 2011-06-21 | 2012-12-27 | Bvw Holding Ag | Medical device comprising boswellic acid |
| RU2476213C1 (ru) * | 2012-02-15 | 2013-02-27 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Воронежская государственная медицинская академия имени Н.Н. Бурденко Министерства здравоохранения и социального развития" (ГБОУ ВПО ВГМА им. Н.Н. Бурденко Минздравсоцразвития России) | Способ комплексного лечения вторичного остеоартроза при ревматоидном артрите |
| JP6270362B2 (ja) * | 2013-07-17 | 2018-01-31 | 日本水産株式会社 | 関節痛改善剤 |
| JP6153436B2 (ja) * | 2013-09-27 | 2017-06-28 | 小林製薬株式会社 | 経口組成物 |
| US9975917B1 (en) | 2017-09-20 | 2018-05-22 | King Saud University | Pentacyclic triterpenoidal derivatives |
| CN111110863A (zh) * | 2020-01-21 | 2020-05-08 | 郑州大学 | 大黄酸磷脂复合物及其制备方法和应用、大黄酸磷脂复合物长循环脂质体及其制备方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3970M (sl) | 1963-11-26 | 1966-02-28 | ||
| GB1155973A (en) * | 1965-06-26 | 1969-06-25 | Ajinomoto Kk | Spiroacetal Diamine Derivatives and their use as Curing Agents for Epoxy Resins |
| DE3347522A1 (de) * | 1983-12-30 | 1985-07-11 | Troponwerke GmbH & Co KG, 5000 Köln | N-glycosylierte carbonsaeureamid-derivate als mittel bei der bekaempfung von erkrankungen des rheumatischen formenkreises |
| DE3602670A1 (de) | 1986-01-29 | 1987-07-30 | Speck Ulrich | Verwendung von n-acetylglucosamin zur therapie degenerativer gelenkprozesse und verwandter erkrankungen |
| US5629351A (en) | 1995-04-13 | 1997-05-13 | Council Of Scientific & Industrial Research | Boswellic acid compositions and preparation thereof |
| DE19531067A1 (de) | 1995-08-23 | 1997-02-27 | Hermann P T Prof Dr Med Ammon | Verwendung von Boswelliasäure und ihren Derivaten zur Hemmung der normalen und gesteigerten Leukozytenelastase- oder Plasminaktivität |
| US5762936A (en) * | 1996-09-04 | 1998-06-09 | Biotics Research Corporation | Antioxidant derived from lentil and its preparation and uses |
| JP4153057B2 (ja) | 1997-03-10 | 2008-09-17 | 中国化薬株式会社 | Ｄ−グルクロノラクトンの製造方法 |
| US6107334A (en) * | 1998-02-23 | 2000-08-22 | Wake Forest University | Dietary control of arachidonic acid metabolism |
| US6761903B2 (en) * | 1999-06-30 | 2004-07-13 | Lipocine, Inc. | Clear oil-containing pharmaceutical compositions containing a therapeutic agent |
| EP1202620A1 (en) * | 1999-05-14 | 2002-05-08 | The Regents of the University of California | Anti-inflammatory therapy for inflammatory mediated infection |
| JP2002153294A (ja) * | 2000-11-21 | 2002-05-28 | Hayashibara Biochem Lab Inc | グルクロン酸類及び／又はｄ−グルクロノラクトンの製造方法とその用途 |
| US6451045B1 (en) * | 2001-02-22 | 2002-09-17 | Alsius Corporation | Heat exchange catheter having a helically wrapped heat exchanger |
| US6541045B1 (en) * | 2002-01-04 | 2003-04-01 | Nutraceutical Corporation | Herbal composition and method for combating inflammation |
-
2003
- 2003-06-27 IT IT001311A patent/ITMI20031311A1/it unknown
-
2004
- 2004-01-06 US US10/562,205 patent/US8343554B2/en not_active Expired - Fee Related
- 2004-06-01 KR KR1020117007487A patent/KR20110039400A/ko not_active Application Discontinuation
- 2004-06-01 WO PCT/EP2004/005875 patent/WO2005002611A1/en active Application Filing
- 2004-06-01 NZ NZ544400A patent/NZ544400A/en unknown
- 2004-06-01 DE DE602004017871T patent/DE602004017871D1/de not_active Expired - Lifetime
- 2004-06-01 BR BRPI0411895A patent/BRPI0411895B1/pt not_active IP Right Cessation
- 2004-06-01 CN CNA2004800177557A patent/CN1812802A/zh active Pending
- 2004-06-01 EP EP04735566A patent/EP1648484B1/en not_active Expired - Lifetime
- 2004-06-01 KR KR1020057024594A patent/KR101119418B1/ko active IP Right Grant
- 2004-06-01 DK DK04735566T patent/DK1648484T3/da active
- 2004-06-01 ES ES04735566T patent/ES2315662T3/es not_active Expired - Lifetime
- 2004-06-01 JP JP2006515812A patent/JP2007513051A/ja active Pending
- 2004-06-01 AU AU2004253242A patent/AU2004253242B2/en not_active Ceased
- 2004-06-01 PT PT04735566T patent/PT1648484E/pt unknown
- 2004-06-01 RU RU2005140573/15A patent/RU2349336C2/ru not_active IP Right Cessation
- 2004-06-01 AT AT04735566T patent/ATE414526T1/de active
- 2004-06-01 CA CA2530494A patent/CA2530494C/en not_active Expired - Fee Related
- 2004-06-01 PL PL04735566T patent/PL1648484T3/pl unknown
- 2004-06-01 SI SI200430968T patent/SI1648484T1/sl unknown
-
2005
- 2005-12-22 IL IL172773A patent/IL172773A/en active IP Right Grant
- 2005-12-23 NO NO20056161A patent/NO333877B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2005140573A (ru) | 2006-06-10 |
| PL1648484T3 (pl) | 2009-04-30 |
| IL172773A (en) | 2010-12-30 |
| BRPI0411895A (pt) | 2006-08-29 |
| EP1648484A1 (en) | 2006-04-26 |
| KR20110039400A (ko) | 2011-04-15 |
| CA2530494C (en) | 2013-04-30 |
| ITMI20031311A0 (it) | 2003-06-27 |
| ATE414526T1 (de) | 2008-12-15 |
| KR20060032147A (ko) | 2006-04-14 |
| RU2349336C2 (ru) | 2009-03-20 |
| ITMI20031311A1 (it) | 2004-12-28 |
| NO20056161L (no) | 2005-12-23 |
| BRPI0411895B1 (pt) | 2015-11-10 |
| AU2004253242B2 (en) | 2010-02-18 |
| EP1648484B1 (en) | 2008-11-19 |
| CN1812802A (zh) | 2006-08-02 |
| WO2005002611A1 (en) | 2005-01-13 |
| DE602004017871D1 (de) | 2009-01-02 |
| JP2007513051A (ja) | 2007-05-24 |
| US8343554B2 (en) | 2013-01-01 |
| PT1648484E (pt) | 2009-01-09 |
| ES2315662T3 (es) | 2009-04-01 |
| AU2004253242A1 (en) | 2005-01-13 |
| CA2530494A1 (en) | 2005-01-13 |
| US20060280811A1 (en) | 2006-12-14 |
| NO333877B1 (no) | 2013-10-07 |
| DK1648484T3 (da) | 2009-01-19 |
| NZ544400A (en) | 2009-04-30 |
| IL172773A0 (en) | 2006-04-10 |
| KR101119418B1 (ko) | 2012-02-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL172773A (en) | Formulations for the treatment of arthritis conditions | |
| TWI345979B (en) | Topical pharmaceutical compositions for the treatment of dermatitis | |
| PT1420801E (pt) | Utilização de fucanos no tratamento de adesões, artrite e psoríase | |
| MY140840A (en) | Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals | |
| TW200510416A (en) | P38 inhibitors and methods of use thereof | |
| MXPA05005223A (es) | Diaminotriazoles utiles como inhibidores de proteinas cinasas. | |
| MY140514A (en) | Triazolopyridine derivatives as inhibitors of lipases and phospholipases | |
| WO2004078116A3 (en) | P38 inhibitors and methods of use thereof | |
| PL1654253T3 (pl) | Podstawione pochodne 3-pirolidynoindolu | |
| TW200509949A (en) | Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents | |
| WO2006116221A3 (en) | Therapeutic combinations for the treatment or prevention of psychotic disorders | |
| MY141528A (en) | Anilinopyrazole derivatives useful for the treatment of diabetes | |
| WO2003106450A8 (de) | Phenylaminopyrimidine und ihre verwendung als rho-kinase inhibitoren | |
| EP1178796A4 (en) | AMINOIMIDAZOLE CARBOXAMIDE SALTS USEFUL IN THE PREVENTION AND TREATMENT OF LIVER DISEASE | |
| EA200500326A1 (ru) | Применение ферментированного экстракта проростков пшеницы в качестве противовоспалительного агента | |
| WO2006078833A3 (en) | Novel coumarin derivatives as ion channel openers | |
| MY140194A (en) | Novel fusidic acid derivatives | |
| MXPA05007253A (es) | Sales novedosas de derivados anticonvulsivantes. | |
| WO2005011611A3 (en) | Bicyclic compounds and compositions as pdf inhibitors | |
| TW200603791A (en) | Compounds and compositions as cathepsin S inhibitors | |
| HK1050203A1 (en) | Novel fusidic acid derivatives. | |
| RS95204A (en) | Combination for the treatment of airway disorders | |
| GB0128071D0 (en) | Medicament | |
| SI1494692T1 (sl) | Topikalni farmacevtski sestavki, ki obsegajo proantocianide, gliciretinsko kislino in telmestein, za zdravljenje dermatitisa | |
| WO2003075926A8 (en) | Use of proton pump inhibitors for the treatment of airway disorders |